Basic Study
Copyright ©The Author(s) 2018.
World J Gastroenterol. Mar 7, 2018; 24(9): 971-981
Published online Mar 7, 2018. doi: 10.3748/wjg.v24.i9.971
Table 5 Antimicrobial susceptibility results for both clarithromycin and fluoroquinolone
GenotypeNumber of gastric biopsy specimens n (%)
P value1
All patients 165 (100)Treatment Naïve 105 (63.6)Previously treated 60 (36.4)
Susceptible (to both)60 (36.4)49 (46.6)11 (18.3)< 0.05
Resistant (to at least one)105 (63.6)56 (53.3)49 (81.6)
Susceptible/resistant to one137 (83.0)92 (87.6)45 (75.0)
Resistant to both28 (17.0)13 (12.4)15 (25.0)0.05